Pathstone Holdings, LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in LXRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$71,925

+$25,478 QoQ

Shares Held

29,969

+0.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 148 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. LXRX ranks #50 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,952	$22,825,735
2	REGN	Regeneron Pharmaceuticals, Inc.	13,825	$8,620,440
3	ASND	Ascendis Pharma A/S	20,248	$5,400,545
4	CYTK	Cytokinetics Inc	47,633	$4,057,854
5	JAZZ	Jazz Pharmaceuticals plc	15,152	$3,651,176
6	PTGX	Protagonist Therapeutics, Inc	28,187	$3,455,162
7	RPRX	Royalty Pharma plc	54,725	$3,068,429
8	ARGX	Argenx SE	3,094	$2,870,519

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$71,925	29,969	+0.7%	Shares	Sole	2026-08-13
2026-03-31	$46,447	29,774	-0.7%	Shares	Sole	2026-05-11
2025-12-31	$34,464	29,969	-0.8%	Shares	Sole	2026-02-13
2025-09-30	$40,780	30,208	+0.6%	Shares	Sole	2025-11-13
2025-06-30	$28,538	30,041	-4.3%	Shares	Defined	2025-08-12
2025-03-31	$14,441	31,397	-41.9%	Shares	Defined	2025-05-15
2024-12-31	$39,997	54,051	-8.3%	Shares	Defined	2025-02-14
2024-09-30	$92,565	58,959	-1.8%	Shares	Defined	2024-11-07
2024-06-30	$100,863	60,038	-4.3%	Shares	Defined	2024-08-14
2024-03-31	$150,540	62,725	+82.1%	Shares	Defined	2024-05-13
2023-12-31	$52,700	34,445	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.